Feature|Articles|November 15, 2024
- Pharmaceutical Executive: November 2024
- Volume 44
- Issue 11
Pharmaceutical Executive: November 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive November 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
AI’s Attention Spanover 1 year ago
Noam Solomon: Bringing the Human Story to AIover 1 year ago
ROI and Rare Disease: Retooling the ‘Gene’ Value Machineover 1 year ago
The Leap Forward: Practical Gains for Pharma AI Useover 1 year ago
Powering Pipelines Forward: Approach Science Differentlyover 1 year ago
Navigating the Current Landscape for Pharma Leadersover 1 year ago
Passage to Asia: Early Access for Innovative Therapiesover 1 year ago
Digital Protection: Q&A with Jeffrey BernsteinAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5